NeuroPace, Inc. (NASDAQ:NPCE) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to NeuroPace’s Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Neuropace Inc (NPCE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 3,406,335 | $23,742,155 | 0.43% | |
| 2. | Soleus Capital Guy Levy | 2,433,168 | $16,959,181 | 1.31% | |
| 3. | Millennium Management Israel Englander | 739,993 | $5,157,751 | +8% | 0% |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 607,890 | $4,236,993 | -2% | 0.21% |
| 5. | Armistice Capital Steven Boyd | 480,000 | $3,345,600 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 62,398 | Large Shareholder | 4,432,948 | 2022-11-22 | Filing | |
| $1.50 | 327,893 | Large Shareholder | 4,370,550 | 2022-11-21 | Filing | |
| $17.00 | 235,000 | Large Shareholder | 235,000 | 2021-04-21 | Filing | |
| $17.00 | 2,352 | Officer | 2,352 | 2021-04-21 | Filing | |
| $17.00 | 588,235 | Large Shareholder | 588,235 | 2021-04-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.45 | 223,991 | Large Shareholder | 5,270,845 | 2024-10-25 | Filing | |
| $6.02 | 147 | Large Shareholder | 5,494,836 | 2024-10-23 | Filing | |
| $6.09 | 4,082 | Large Shareholder | 5,494,983 | 2024-10-22 | Filing | |
| $6.10 | 3,720 | Large Shareholder | 5,499,065 | 2024-10-21 | Filing | |
| $6.29 | 4,878 | Large Shareholder | 5,502,785 | 2024-10-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,460,716 | $25,369,982 | 0% | |
| 2. | 468,081 | $4,825,915 | 0% | |
| 3. | 413,106 | $4,259,123 | 0% | |
| 4. | 115,996 | $1,196,166 | 0% | |
| 5. | 86,502 | $891,835 | 0% |
News See All
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's Second Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode.
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's First Quarter 2024 Conference Call. As a reminder, this call is being recorded.
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript
NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.33.
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings and welcome to the NeuroPace, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
12 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023.
20 Countries With Highest Rate of Epilepsy
In this article, we will take a detailed look at the 20 countries with the highest rates of epilepsy with insights into number of epilepsy cases by country and population.
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's Second Quarter 2023 Earnings Conference Call. As a reminder, this conference is being recorded.
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to NeuroPace's First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.